Sympatholytic and hypoglycemic action of certain biguanide derivatives
Avakian, O.M.; Pogosian, A.V.; Stepanian, N.O.
Farmakologiia i Toksikologiia 36(5): 707-711
1973
ISSN/ISBN: 0014-8318 PMID: 4802337 Document Number: 70277
Document emailed within 1 workday
Related Documents
Zubchenko, V.G.; Kulik, M.I. 1973: Synthesis of azolidine derivatives with possible hypoglycemic action. IX. 2'-Arylsulfonyl-3-aryl-(alkyl-) derivatives of 2-iminothiazolidone-4 Farmatsevtychnyi Zhurnal 28(5): 28-33Polacek, I.; Ouart, J. 1978: Hypoglycemic activity of amine derivatives. a possible mode of action Arzneimittel-Forschung 28(6): 984-989
Plauchu, M.; Kressmann, J.; de Montgolfier, R.; Wittlin, R. 1971: Value of an oral hypoglycemic medication combining a sulfonamide with a biguanide Diabiphage (chlorpropamide, Metformin) Lyon Medical 225(8): 763-765
Härtfelder, G.; Lessenich, H.; Schmitt, K. 1972: Phenbutolol (Hoe 893d), a new highly efficient -sympatholytic agent with long action duration Arzneimittel-Forschung 22(5): 930-932
Vázquez, A.; Moya, G.; Ricoy, J.R. 1970: Neurological aspects of hypoglycemic coma; hypoglycemic comas of medical origin caused by hypoglycemic agents Revista Clinica Espanola 117(2): 157-168
Vicini, P.; Amoretti, L.; Caretta, A. 1992: Synthesis, hypoglycemic and toxicological evaluation of new 1,2-benzisothiazolyl derivatives Farmaco 47(3): 265-274
Polacek, I.; Breuer, H. 1978: Hypoglycemic activity of amine derivatives. Preliminary observations Arzneimittel-Forschung 28(5): 791-793
Sugiyama, Y. 2002: Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 416-421
Sugiyama, Y.; Murase, K.; Ikeda, H. 2000: Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects Nihon Rinsho. Japanese Journal of Clinical Medicine 58(2): 370-375
Katsuno, T.; Miyagawa, J.-I. 2012: Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 693-698
Bozdağ, O.; Verspohl, E.J.; Ertan, R. 2000: Synthesis and hypoglycemic activity of some new flavone derivatives. 3rd communication: 3'-flavonyl-2,4-thiazolidinediones Arzneimittel-Forschung 50(7): 626-630
Frati-Munari, A.C.; Ríos Gil, U.; Ariza-Andraca, C.R.; Islas Andrade, S.; López Ledesma, R. 1989: Duration of the hypoglycemic action of Opuntia streptacantha Lem Archivos de Investigacion Medica 20(4): 297-300
De Sereday, M.S.; Efron, H.R.; De Compte, D.V.; Raffo del Campo, M.A. 1971: Hypoglycemic action of fenfluramine in obese diabetics Prensa Medica Argentina 58(20): 1030-1033
Brzozowski, Z.; Magiełka, S.; Wójcikowski, C. 1983: Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea Acta Poloniae Pharmaceutica 40(2): 134-138
Ainapure, S.S.; Dhar, H.L. 1986: Role of cholinergic mechanism in the hypoglycemic action of B. pertussis vaccine Japanese Journal of Experimental Medicine 56(4): 147-149
Imamura, Y.; Kimachi, K.; Nagase, S.; Otagiri, M. 1990: Hypoglycemic action and disposition of gliclazide in normal and analbuminemic rats Archives Internationales de Pharmacodynamie et de Therapie 304: 44-54
Ng, F.M.; Blaskett, E.; Larsen-Disney, P. 1985: A cellular mediator for the hypoglycemic action of a human growth hormone fragment (hGH 4-15) Biochemistry International 11(5): 739-746
El Fouhil, A.F.; Ahmed, A.M.; Atteya, M.; Mohamed, R.A.; Moustafa, A.S.; Al-Roalle, A.H.; Darwish, H.H. 2013: Hypoglycemic effects of date seed extract. Possible mechanism of action, and potential therapeutic implications Saudi Medical Journal 34(11): 1125-1132
Hazard, J. 1976: Hypoglycemic complications induced by hypoglycemic sulfonamides. Recall of pharmacological basis of their therapeutic use La Nouvelle Presse Medicale 5(14): 903-905
Kunoh, Y.; Iguchi, A.; Gotoh, M.; Nomura, T.; Shibata, M.; Sakamoto, N. 1986: Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 280(2): 302-313